Matthew Kurian: Fantastic 1st day at the 2024 San Antonio Breast Cancer Symposium
Matthew Kurian, Assistant Professor of medicine at the University of Kentucky College of Medicine, shared a post on LinkedIn:
“Fantastic 1st day at the 2024 San Antonio Breast Cancer Symposium!
Amazing presentations and always better company with mentees, mentors, friends, and colleagues. I also had the privilege of being part of my first steering committee today as an early career faculty member and left feeling energized and enthusiastic about the changing landscape of breast oncology and humbled to be in the same room as many passionate breast oncology leaders across the country.
Ready for day 2!”
Jasmin Hundal, Hematology Oncology Fellow at Cleveland Clinic, reshared the post on LinkedIn, adding:
“It was an incredible first day at the 2024 San Antonio Breast Cancer Symposium!
The sessions were insightful and thought-provoking, and I appreciated the opportunity to connect with mentors, colleagues, and friends while forming new professional relationships.
I am grateful for Matthew Kurian, MD guidance and mentorship.
Looking forward to an exciting Day 2!”
Matthew Kurian is a staff hematology/oncology physician at St. Elizabeth Healthcare and an assistant professor of medicine at the University of Kentucky College of Medicine. His primary focus lies in breast and genitourinary (GU) cancers, where he combines clinical practice with research to improve patient outcomes. Dr. Kurian has expertise in radioligand treatments, including Lu-177, and has published several peer-reviewed articles on various oncology topics.He completed his oncology fellowship at the NCI-designated University Hospitals/Case Comprehensive Cancer Center, where he also served as the Chief Fellow of the Hematology/Oncology Fellowship Program for the 2022-2023 academic year.
Jasmin Hundal is a Hematology Oncology Fellow at Cleveland Clinic and a board-certified internal medicine physician. She is also a Resident Physician at the University of Connecticut. Her research centers on the impact of modifiable risk factors like diet, metabolism, and the microbiome on cancer and its treatment.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023